• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种预测模型算法,以在美国行政索赔数据中识别 2 型糖尿病成人中的过敏反应。

Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data.

机构信息

HealthCore, Inc., Wilmington, Delaware, USA.

RTI Health Solutions, Waltham, Massachusetts, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):918-926. doi: 10.1002/pds.5257. Epub 2021 May 5.

DOI:10.1002/pds.5257
PMID:33899314
Abstract

PURPOSE

To use medical record adjudication and predictive modeling methods to develop and validate an algorithm to identify anaphylaxis among adults with type 2 diabetes (T2D) in administrative claims.

METHODS

A conventional screening algorithm that prioritized sensitivity to identify potential anaphylaxis cases was developed and consisted of diagnosis codes for anaphylaxis or relevant signs and symptoms. This algorithm was applied to adults with T2D in the HealthCore Integrated Research Database (HIRD) from 2016 to 2018. Clinical experts adjudicated anaphylaxis case status from redacted medical records. We used confirmed case status as an outcome for predictive models developed using lasso regression with 10-fold cross-validation to identify predictors and estimate the probability of confirmed anaphylaxis.

RESULTS

Clinical adjudicators reviewed medical records with sufficient information from 272 adults identified by the anaphylaxis screening algorithm, which had an estimated Positive Predictive Value (PPV) of 65% (95% confidence interval [CI]: 60%-71%). The predictive model algorithm had a c-statistic of 0.95. The model's probability threshold of 0.60 excluded 89% (84/94) of false positives identified by the screening algorithm, with a PPV of 94% (95% CI: 91%-98%). The model excluded very few true positives (15 of 178), and identified 92% (95% CI: 87%-96%) of the cases selected by the screening algorithm.

CONCLUSIONS

Predictive modeling techniques yielded an accurate algorithm with high PPV and sensitivity for identifying anaphylaxis in administrative claims. This algorithm could be considered in future safety studies using similar claims data to reduce potential outcome misclassification.

摘要

目的

使用医疗记录审核和预测建模方法开发和验证一种算法,以识别 2 型糖尿病(T2D)成年患者的过敏反应。

方法

开发了一种常规筛选算法,该算法优先考虑敏感性以识别潜在的过敏反应病例,包括过敏或相关症状和体征的诊断代码。该算法应用于 2016 年至 2018 年 HealthCore 综合研究数据库(HIRD)中的 T2D 成年患者。临床专家根据删节后的医疗记录裁定过敏反应病例的状态。我们使用拉索回归和 10 倍交叉验证开发的预测模型来识别预测因子并估计确认过敏反应的概率,将确诊病例状态作为结果。

结果

临床审核员根据过敏筛选算法确定的 272 名成年人的医疗记录进行了审查,该记录具有 65%(95%置信区间[CI]:60%-71%)的估计阳性预测值(PPV)。预测模型算法的 C 统计量为 0.95。模型的概率阈值为 0.60,排除了筛选算法确定的 89%(84/94)的假阳性,其 PPV 为 94%(95%CI:91%-98%)。模型排除了极少数真正的阳性(178 例中的 15 例),并识别了筛选算法选择的 92%(95%CI:87%-96%)的病例。

结论

预测建模技术产生了一种准确性高、PPV 和敏感性高的算法,可用于识别行政索赔中的过敏反应。在未来使用类似索赔数据的安全性研究中,可以考虑使用该算法来减少潜在的结局错误分类。

相似文献

1
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data.开发和验证一种预测模型算法,以在美国行政索赔数据中识别 2 型糖尿病成人中的过敏反应。
Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):918-926. doi: 10.1002/pds.5257. Epub 2021 May 5.
2
Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel.验证食品和药物管理局 Mini-Sentinel 中的过敏反应。
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1205-13. doi: 10.1002/pds.3505. Epub 2013 Sep 5.
3
Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.开发并验证一种在行政索赔数据库中识别甲型血友病患者的算法。
Value Health. 2018 Sep;21(9):1098-1103. doi: 10.1016/j.jval.2018.03.008. Epub 2018 May 7.
4
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data".对致编辑信的回复,信的内容是关于“在美国行政索赔数据中开发和验证用于识别2型糖尿病成人患者过敏反应的预测模型算法”
Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):110-111. doi: 10.1002/pds.5376. Epub 2021 Oct 27.
5
Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.北京药物警戒数据库中一种识别药物性过敏反应算法的开发与验证
Int J Clin Pharm. 2018 Aug;40(4):862-869. doi: 10.1007/s11096-018-0594-z. Epub 2018 Feb 20.
6
Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.预测模型算法在理赔数据中识别早期和晚期 ER+/HER2- 乳腺癌。
Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):171-178. doi: 10.1002/pds.4681. Epub 2018 Nov 9.
7
Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.在美国一个大型行政索赔数据库中,开发并验证一种用于识别癫痫患者队列中尿潴留情况的算法。
Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):413-21. doi: 10.1002/pds.3975. Epub 2016 Feb 17.
8
The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink.利用自然语言处理技术在疫苗安全数据链中的五个医疗系统中识别与疫苗相关的过敏反应。
Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):182-188. doi: 10.1002/pds.4919. Epub 2019 Dec 3.
9
A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data.使用行政和索赔数据对过敏反应(包括过敏性休克和血管神经性水肿)进行验证方法的系统评价。
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:240-7. doi: 10.1002/pds.2327.
10
Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning.利用自然语言处理和机器学习改进医疗产品安全监测中过敏反应识别方法。
Am J Epidemiol. 2023 Feb 1;192(2):283-295. doi: 10.1093/aje/kwac182.

引用本文的文献

1
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic Research.医疗保健综合研究数据库(HIRD)作为药物流行病学研究的真实世界数据源。
Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70110. doi: 10.1002/pds.70110.
2
Developing an AI-based prediction model for anaphylactic shock from injection drugs using Japanese real-world data and chemical structure-based analysis.利用日本真实世界数据和基于化学结构的分析开发用于注射药物过敏反应的人工智能预测模型。
Daru. 2024 Jun;32(1):253-262. doi: 10.1007/s40199-024-00511-4. Epub 2024 Apr 5.
3
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
GLP-1 受体激动剂新使用者发生过敏反应的风险:一项队列研究。
Diabetes Care. 2024 Apr 1;47(4):712-719. doi: 10.2337/dc23-1911.
4
Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning.利用自然语言处理和机器学习改进医疗产品安全监测中过敏反应识别方法。
Am J Epidemiol. 2023 Feb 1;192(2):283-295. doi: 10.1093/aje/kwac182.